Abeona Therapeutics (ABEO) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $207.5 million.
- Abeona Therapeutics' Cash & Current Investments rose 8852.86% to $207.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.5 million, marking a year-over-year increase of 8852.86%. This contributed to the annual value of $98.1 million for FY2024, which is 8654.97% up from last year.
- Abeona Therapeutics' Cash & Current Investments amounted to $207.5 million in Q3 2025, which was up 8852.86% from $225.9 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Cash & Current Investments ranged from a high of $225.9 million in Q2 2025 and a low of $23.5 million during Q3 2022
- Over the past 5 years, Abeona Therapeutics' median Cash & Current Investments value was $62.7 million (recorded in 2024), while the average stood at $83.6 million.
- As far as peak fluctuations go, Abeona Therapeutics' Cash & Current Investments plummeted by 6690.99% in 2022, and later surged by 23157.1% in 2024.
- Over the past 5 years, Abeona Therapeutics' Cash & Current Investments (Quarter) stood at $50.9 million in 2021, then grew by 3.09% to $52.5 million in 2022, then rose by 0.15% to $52.6 million in 2023, then skyrocketed by 86.55% to $98.1 million in 2024, then soared by 111.56% to $207.5 million in 2025.
- Its Cash & Current Investments was $207.5 million in Q3 2025, compared to $225.9 million in Q2 2025 and $152.7 million in Q1 2025.